Cargando…
Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial
Chinese herbal medicine (CHM) might have benefits in patients with non-diabetic chronic kidney disease (CKD), but there is a lack of high-quality evidence, especially in CKD4. This study aimed to assess the efficacy and safety of Bupi Yishen Formula (BYF) vs. losartan in patients with non-diabetic C...
Autores principales: | Mao, Wei, Yang, Nizhi, Zhang, Lei, Li, Chuang, Wu, Yifan, Ouyang, Wenwei, Xu, Peng, Zou, Chuan, Pei, Chunpeng, Shi, Wei, Zhan, Jihong, Yang, Hongtao, Chen, Hongyu, Wang, Xiaoqin, Tian, Yun, Yuan, Fang, Sun, Wei, Xiong, Guoliang, Chen, Ming, Guan, Jianguo, Tang, Shuifu, Zhang, Chunyan, Liu, Yuning, Deng, Yueyi, Lin, Qizhan, Lu, Fuhua, Hong, Weihong, Yang, Aicheng, Fang, Jingai, Rao, Jiazhen, Wang, Lixin, Bao, Kun, Lin, Feng, Xu, Yuan, Lu, Zhaoyu, Su, Guobin, Zhang, La, Johnson, David W, Zhao, Daixin, Hou, Haijing, Fu, Lizhe, Guo, Xinfeng, Yang, Lihong, Qin, Xindong, Wen, Zehuai, Liu, Xusheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941267/ https://www.ncbi.nlm.nih.gov/pubmed/33708125 http://dx.doi.org/10.3389/fphar.2020.627185 |
Ejemplares similares
-
Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease
por: Mao, Wei, et al.
Publicado: (2015) -
Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation
por: Zhang, Difei, et al.
Publicado: (2021) -
Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy
por: Fang, Jingai, et al.
Publicado: (2022) -
Bupi Yishen formula attenuates kidney injury in 5/6 nephrectomized rats via the tryptophan-kynurenic acid-aryl hydrocarbon receptor pathway
por: Mo, Yenan, et al.
Publicado: (2021) -
Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule)
por: Fang, Jingai, et al.
Publicado: (2013)